phentermine hcl c-iv

Generic: phentermine hcl c-iv

Labeler: direct_rx
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name phentermine hcl c-iv
Generic Name phentermine hcl c-iv
Labeler direct_rx
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

phentermine hydrochloride 15 mg/1

Manufacturer
Direct_Rx

Identifiers & Regulatory

Product NDC 72189-365
Product ID 72189-365_2c4c9dee-895f-30b5-e063-6394a90a3523
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA205019
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2022-07-25

Pharmacologic Class

Classes
appetite suppression [pe] increased sympathetic activity [pe] sympathomimetic amine anorectic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72189365
Hyphenated Format 72189-365

Supplemental Identifiers

RxCUI
968766
UNII
0K2I505OTV

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name phentermine hcl c-iv (source: ndc)
Generic Name phentermine hcl c-iv (source: ndc)
Application Number ANDA205019 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 15 mg/1
source: ndc
Packaging
  • 30 CAPSULE in 1 BOTTLE (72189-365-30)
source: ndc

Packages (1)

Ingredients (1)

phentermine hydrochloride (15 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2c4c9dee-895f-30b5-e063-6394a90a3523", "openfda": {"unii": ["0K2I505OTV"], "rxcui": ["968766"], "spl_set_id": ["e4a2996e-2bfa-376f-e053-2995a90a0ed1"], "manufacturer_name": ["Direct_Rx"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (72189-365-30)", "package_ndc": "72189-365-30", "marketing_start_date": "20220725"}], "brand_name": "Phentermine HCL C-IV", "product_id": "72189-365_2c4c9dee-895f-30b5-e063-6394a90a3523", "dosage_form": "CAPSULE", "pharm_class": ["Appetite Suppression [PE]", "Increased Sympathetic Activity [PE]", "Sympathomimetic Amine Anorectic [EPC]"], "product_ndc": "72189-365", "dea_schedule": "CIV", "generic_name": "Phentermine HCL C-IV", "labeler_name": "Direct_Rx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Phentermine HCL C-IV", "active_ingredients": [{"name": "PHENTERMINE HYDROCHLORIDE", "strength": "15 mg/1"}], "application_number": "ANDA205019", "marketing_category": "ANDA", "marketing_start_date": "20220725", "listing_expiration_date": "20261231"}